Advanced 3D in vitro models (organoids or tissue cultures) may constitute an alternative test system for initial screening and characterization of lead compounds in early development stages. 3D tissue structures have been proven to more closely reproduce behavior and characteristics of a living organism in comparison to traditional 2D cell cultures in dishes. [3,4] For such advanced in vitro models, a large range of automated test systems and analysis methods would be potentially available, so that testing procedures could be parallelized to increase throughput. This prospect has fueled rapid progress in developing 3D in vitro models of individual organs of the human body for pharmaceutical and toxicological research. Such model systems need to be carefully engineered to faithfully reproduce physiological effects, pharmacokinetics, and toxicity that may occur within a human body in order to enable successful identification of new drug compounds and the corresponding mechanisms of action.To realize advanced in vitro models, not only the 3D nature of a human body and its tissues needs to be considered, but also the potential interplay of organs. More recently, microphysiological systems (MPSs) emerged in an effort to better recapitulate in vivo conditions of human physiology and to better control in vitro cell and tissue culturing conditions. [5][6][7][8][9][10] MPSs are in vitro platforms designed to model the spatial, chemical, structural, and physiological elements of in vivo cellular environments and include, in most cases, a combination of advanced cell-culture or tissue models and microfluidic technology. Important features of MPSs include the use of more complex multicellular or tissue structures and the possibility to expose cells to cues that they also experience in their native environment in the human body, such as mechanical cues in the form of flow-induced shear stress, [11,12] stretching, [13,14] or biochemical stimuli. [15][16][17] Key features of MPSs that are usually combined in a single system include: a) advanced 3D tissue or organ models, b) the presence of culture medium flow or perfusion, and c) fluidic interconnection and potential interaction of different organ models through the liquid phase: a) 3D tissue models feature increased functionality and a more organotypic cellular microenvironment in comparison to Studying and understanding of tissue and disease mechanisms largely depend on the availability of suitable and representative biological model systems. These model systems should be carefully engineered and faithfully reproduce the biological system of interest to understand physiological effects, pharmacokinetics, and toxicity to better identify new drug compounds. By relying on microfluidics, microphysiological systems (MPSs) enable the precise control of culturing conditions and connections of advanced in vitro 3D organ models that better reproduce in vivo environments. This review focuses on transferable in vitro organ models and integrated MPSs that host these transferable biologic...